Screener
Neuropace, Inc. NPCE Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
| (in thousands, except for share and per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $22,826 | $19,501 | $44,829 | $37,822 |
| Cost of goods sold | 3,920 | 3,288 | 7,912 | 6,478 |
| Gross profit | 18,906 | 16,213 | 36,917 | 31,344 |
| Operating expenses: | ||||
| Sales and marketing | 12,124 | 11,489 | 23,707 | 21,894 |
| Research and development | 6,898 | 6,845 | 14,087 | 14,285 |
| General and administrative | 5,027 | 6,068 | 9,871 | 10,114 |
| Total operating expenses | 24,049 | 24,402 | 47,665 | 46,293 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Neuropace, Inc.'s total revenue?
- Neuropace, Inc. (NPCE) reported total revenue of $22.83M in Q2 2026.
- How has Neuropace, Inc.'s total revenue changed year-over-year?
- Neuropace, Inc.'s total revenue increased by 17.1% year-over-year, from $19.5M to $22.83M.
- What is the long-term trend for Neuropace, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s total revenue has grown at a 20.7% compound annual growth rate (CAGR), from $45.18M to $95.97M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Neuropace, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude